Moreover, the increased blood glucose level (Figure 4F) and serum inflammatory factor [tumor necrosis factor-α (TNF-α), interleukin-1β (IL-1β), IL-6] levels (Figures 4G–I) induced by DM were also effectively inhibited after SPC treatment. The gene discussed is IL6; the disease is diabetes mellitus.